Why were the results of randomized trials on the clinical utility of fetal fibronectin negative? A systematic review of their study designs

Jolande Y. Vis, Femke F. Wilms, Martijn A. Oudijk, Patrick M.M. Bossuyt, Joris A.M. Van Der Post, William A. Grobman, Ben Willem J. Mol

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Why were the results of randomized trials on the clinical utility of fetal fibronectin negative? A systematic review of their study designs'. Together they form a unique fingerprint.

Medicine & Life Sciences